CoreBioLabs is a biotechnology startup based in the United States, specializing in clinical diagnostics. Established in 2012, the company holds several significant accreditations, including being CAP-accredited and CLIA-certified, which attests to its commitment to high standards of quality and reliability in its services.
The core team at CoreBioLabs comprises Board Certified Molecular Biologists and Pathologists, ensuring the delivery of accurate and comprehensive results. The company's commitment to leveraging state-of-the-art equipment underscores its dedication to precision and reliability, key attributes in the healthcare sector.
While specific details about the latest investment remain undisclosed, CoreBioLabs holds promise as a hub of innovation in the clinical diagnostics space. Its emphasis on patient care and provider customer service positions it favorably in a competitive industry, making it a potential candidate for venture capital investment.
There is no investment information
No recent news or press coverage available for CoreBioLabs.